An interventional study of In Patıents Wıth Dıabetıc Foot Ulcer, Effect On Paın And Anxıety Of Stress Ball Use Durıng Sharp Debrıdement in Diabetic Foot Ulcer, sponsored by Harran University. Recruiting at 1 site in Turkey. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-03-18.
Sponsored by Harran University · Not applicable, Interventional, and Health services research
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 48 studies in Diabetic Foot with a site in Turkey — 14 open to participants now, 18 under way, none of them phase 3. Diabetic Foot · Turkey.
Among the 48 studies in Diabetic Foot with a site in Turkey, this one is the 17th largest by planned enrollment of the 39 interventional ones that give a count, is one of 9 that started in 2023, is one of 36 with no phase, reaches primary completion later than 2 of the 17 other live ones, and was the 21st registered.
1,079 studies on the registry are indexed under Diabetic Foot; 221 are open to participants now.
Browse Diabetic Foot studies →14 of the 48 studies in Diabetic Foot with a site in Turkey are open now. Recruiting first, the newest first:
Sakarya University · Sites in Turkey
Ages 22+ · Healthy volunteers
Inonu University · Sites in Turkey
Ages 18+
Cukurova University · Sites in Turkey
Ages 18+
Ankara City Hospital Bilkent · Sites in Turkey
Ages 18+
University of Beykent · Sites in Turkey
Ages 18+
A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →
Of the 139 Diabetic Foot studies recruiting now, 98 (71%) set no upper age limit and 12 (9%) stop at 75 or younger; 5 take children under 18; 11 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
48 studies; the count open now beside each. This study's row is marked.
First in 2007; this study’s year is marked. 9 started in 2023.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 76 is above the median of 60 across 849 interventional studies indexed under Diabetic Foot.
Median enrollment 73 across the 39 interventional studies, 84 across the 9 observational. Of the 28 that completed or were terminated, 1 (4%) have results posted.
This tab as a report to print or save as PDF → With an account.
3 of 48 have an industry lead sponsor. The 10 most frequent:
Harran University is the lead sponsor of 64 studies on the registry; 21 are open to participants now.
Harran University has 5 studies filed under Diabetic Foot — fewer than ten, so there is no comparison to draw.
2 of the studies in Diabetic Foot with a site in Turkey that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07119983Cukurova UniversityEffect of Stress Ball Applied During Surgical Debridement/Dressing on Pain, Distress, and Physiological Parameters in Patients With Diabetic Foot Ulcers | 2027-01-01 |
| NCT07813676Siirt UniversityEffect of Digital-Supported Foot Care Education in Individuals With Type 2 Diabetes | 2027-07-15 |
Add all 2 to your calendar (.ics) → With an account.
Among the 48 studies in Diabetic Foot with a site in Turkey, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Diabetic foot ulcer; It is a disease used to describe a series of lower extremity complications that may occur together with infection, ulceration or gangrene in individuals with diabetes and is coded as S91.3 and S91.8 in the International Classification of Diseases (ICD). Sharp debridement, one of the treatments for diabetic foot ulcers, is a short-term application performed with a sharp scalpel or scissors at the patient's bed or in outpatient clinic conditions. It should be performed by a skilled clinician with wound training. To our knowledge, no study has been found in the literature regarding the use of a stress ball as an intervention to prevent pain and anxiety during sharp debridement. In line with this information, this study will examine the effect of stress ball use on the pain and anxiety levels of patients with diabetic foot ulcers during wound debridement.
The annual number of patients hospitalized with diabetic foot ulcer treatment is 543, and the sample calculation of the study was determined using the G*Power program. Since there was no previous study conducted in the same study group, a study examining the effect of stress ball on pain in invasive procedures was taken as reference in the calculation of the sample. In this study, it was predicted that the difference between pain intensities would be evaluated with a t test, and the effect value was predicted to be 0.70 with a 95% confidence interval and 80% power, and it was calculated that 34 participants would be sufficient for the sample. Considering possible losses from the study (hospitalization, death, changing treatment center, etc.), a total of 76 patients, 38 in each group, were aimed to be included in the study.
As a data collection tool; Introductory Information Form, Meggit-Wagner Classification, Visual Comparison Scale and State Anxiety Scale (STAI) will be used.
Intervention Group: Patients in this group participating in the study will be given a stress ball and asked to use it before the debridement procedure, and each patient will be debrided by the same person throughout the procedure. The patient's pain and anxiety will be evaluated by a nurse independent of the research before and after the debridement procedure.
Control Group: The patient's pain and anxiety will be evaluated by a nurse independent of the research before and during the debridement procedure, without any intervention to the patients.
Stress ball use: Before starting the study, the researchers explained to the patients theoretically how to use the stress ball and demonstrated it practically. Then, the patient was asked to use the ball and it was confirmed whether he was using it correctly. Patients will be asked to count to three, squeeze the ball once and then relax it, inhale each time they squeeze the ball, and exhale when they relax it. The stress ball used is made of medium hardness and high quality silicone. The balls will be provided by the researchers and given to the patients. Patients will use the stress ball throughout the debridement procedure and will continue to use it until the procedure is completed. Statistical significance level will be accepted as p \<0.05.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
No Intervention: The patient's pain and anxiety will be evaluated by a nurse independent of the research before and during the debridement procedure, without any intervention to the patients
Intervention Group: Patients in this group participating in the study will be given a stress ball and asked to use it before the debridement procedure, and each patient will be debrided by the same person throughout the procedure. The patient's pain and anxiety will be evaluated by a nurse independent of the research before and after the debridement procedure.
Other: In Patıents Wıth Dıabetıc Foot Ulcer, Effect On Paın And Anxıety Of Stress Ball Use Durıng Sharp Debrıdement
Patients in this group participating in the study will be given a stress ball and asked to use it before the debridement procedure, and each patient will be debrided by the same person throughout the procedure. The patient's pain and anxiety will be evaluated by a nurse independent of the research before and after the debridement procedure.
Introductory Information Form
Introductory information formula section by examining studies conducted with products diagnosed with diabetic foot ulcers. Promotional information regime; People's birth year, education level, employment status, income level, place of residence, year of diabetes diagnosis, etc. A total of 13 questions will be asked about.
Time frame: at enrollment
Meggit-Wagner classification of diabetic foot
This classification system, which is based on the depth of the wound and graded in six categories from stage 0 to stage 5 according to the presence of osteomyelitis and gangrene, is evaluated with observational findings, excluding the depth of injuries. There are no limits of ischemia and cryptocurrencies and there is no presence of neuropathy. However, the positive effects of considering this in the improvement process of diabetic foot killing are known. The classification of the wound will be evaluated by a specialist physician and recorded by a certificate independent of the research. Higher scores mean a worse outcome for diabetic food ulcer.
Time frame: baseline
Visual Comparison Scale
On a scale from 0 to 10, 0 = no pain and 10 = unbearable pain. The severity of the patient's pain will be recorded before and during debridement (when the patient feels the pain decrease or increase) by a nurse independent of the study
Time frame: immediately before and after the procedure
State Anxiety scale (STAI)
Anxiety level is scored as "(1) not at all, (2) a little, (3) a lot and (4) completely" in STAI-I. Items 3, 4, 6, 7, 9, 12, 13, 14, 17, 18 in the inventory are positive for 40 (increasing the total anxiety score), 1, 2, 5, 8, 10, 11, 15, 16, Negative scoring (reducing the total anxiety score) is given for items 19 and 20. The total score for reverse expressions is subtracted from the total score obtained for direct expressions. In scoring, a score between 1 (or -1) and 4 (or -4) is expected for each item, depending on the positive or negative feature of the item, and 50 is added to the total score to be obtained. The highest score is 80, the lowest score is 20. The higher the total anxiety score, the higher the person's anxiety level is interpreted. Before and during debridement, the State Anxiety Scale will be evaluated and recorded by a nurse independent of the research.
Time frame: immediately before and after the procedure
Plan to share: No
Started Dec 2023 (actual). Primary completion is estimated for Mar 2024, 2 months after the start.
Of 243 non-industry interventional studies with no phase under Diabetic Foot, half reached primary completion within 21 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 37. This study's planned 2 months is below that.
Counting every sponsor, half of 347 studies reached it within 22 months; a quarter within 9 and three quarters within 37.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Harran University